Evidence map›Paper›PMID 39901346›Full record

ArticleEthnicity & health2025

Racism, discrimination, medical mistrust, stigma, and lung cancer screening: a scoping review.

Sreekar Miriyala, Kirsten V Nguyen, Anika Park, Timothy Hwang, Melinda C Aldrich, Jennifer Richmond

Abstract readScoping Review
In one paragraph

Article in Ethnicity & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Reducing Stigma in Lung Cancer Screening: Co-Design of a Targeted Resource for Health Professionals in Australia.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sreekar MiriyalaIcahn School of Medicine at Mount Sinai, New York, NY, USA.
Kirsten V NguyenVanderbilt University School of Medicine, Nashville, TN, USA.
Anika ParkHarvard Medical School, Boston, MA, USA.
Timothy HwangVanderbilt University, Nashville, TN, USA.
Melinda C AldrichDivision of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Jennifer RichmondDivision of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Funding

Addressing racial disparities in lung cancer screeningR01CA251758 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALDRICH, MELINDA, BLUME, JEFFREY D. · 2021 to 2025
$2.4M
Understanding determinants of racial disparities in lung cancer incidenceU01CA253560 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALDRICH, MELINDA · 2020 to 2023
$2.3M
Developing a Trustworthy Multilevel Intervention to Improve Lung Cancer ScreeningR00CA277366 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICHMOND, JENNIFER ANN · 2023 to 2025
$701k
Developing a Trustworthy Multilevel Intervention to Improve Equity in Lung Cancer ScreeningK99CA277366 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHMOND, JENNIFER ANN · 2023 to 2023
$109k
AHRQ HHS T32 HS026122NCI NIH HHS K99 CA277366NCI NIH HHS L60 CA264691NCI NIH HHS R00 CA277366NCI NIH HHS R01 CA251758NCI NIH HHS U01 CA253560
6 · The paper itself

Abstract

objectiveLung cancer screening can reduce lung cancer-specific mortality, but it is widely underutilized, especially among minoritized populations that bear a disproportionate burden of lung cancer, such as Black Americans. Racism, discrimination, medical mistrust, and stigma contribute to lower uptake of preventive screenings in general, but the role these factors play in lung cancer screening is unclear. We therefore conducted a scoping review to synthesize the literature regarding how racism, discrimination, medical mistrust, and stigma relate to lung cancer screening.

designInformed by PRISMA-ScR guidelines, we searched five databases for relevant literature, and two trained researchers independently reviewed articles for relevance. We conducted a narrative, descriptive analysis of included articles.

resultsA total of 45 studies met our inclusion criteria. Most articles reported on medical mistrust or one of its cognates (e.g. trust and distrust,

conclusionsOverall, novel interventions are needed to promote trust and reduce mistrust, distrust, and stigma in lung cancer screening initiatives. Dedicated efforts are especially needed to understand and address the roles that racism and discrimination may play in lung cancer screening.

Indexed as

Early Detection of CancerLung NeoplasmsRacismSocial StigmaTrustBlack or African AmericanHumansdiscriminationLung cancer screeningmistrustracismSDG 10: Reduced inequalitiesSDG 3: Good health and well-beingstigma

Identifiers

PMID39901346
PMCPMC11961322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.